查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606328

脑血管摄影市场：按产品、给药途径、应用和最终用户 - 全球预测 2025-2030

Cerebral Angiography Market by Product (Computed Tomography Angiography, Magnetic Resonance Angiography, X-ray Angiography), Route of Administration (Transfemoral, Transradial), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年脑血管摄影市场价值为14.1亿美元，预计到2024年将达到15.1亿美元，复合年增长率为6.85%，到2030年预计将达到22.5亿美元。

脑血管摄影是一种可视化大脑血管的诊断影像技术，在各种神经系统疾病（包括动脉瘤、中风和血管畸形）的诊断和治疗中发挥至关重要的作用。脑血管摄影的需求在于其能够提供脑血管系统的详细影像，从而实现准确的评估和干预计划。其应用范围广泛，包括医院、专科诊所和研究机构，用于诊断和治疗目的。最终用途范围广泛，包括在神经科、介入放射学单位和神经血管疾病研究中越来越多的使用。推动市场成长的主要因素是脑血管疾病盛行率的上升、影像处理系统的技术进步以及对微创手术的需求不断增加。潜在的机会包括开发可携式且经济高效的成像解决方案、增强数位成像技术以及改进显影剂以获得更清晰、更安全的影像。对用于影像分析的人工智慧的投资以及用于预测诊断的机器学习的整合指向了重要的成长途径。然而，市场扩张面临高昂的治疗成本、严格的监管核准以及对熟练医务人员的需求的挑战。此外，低收入地区的进入有限也是采用的障碍。为了应对这些挑战，技术创新可以专注于降低成本、扩大远距远端医疗能力以及为医务人员制定培训计划。在不断的技术进步以及医疗保健提供者和高科技公司之间的合作伙伴关係的推动下，市场竞争激烈且充满活力。企业可以透过投资人工智慧主导的诊断工具的研发和加强跨部门合作来利用新兴趋势。透过解决当前的限制并专注于这些创新领域，相关人员可以利用脑血管摄影市场的成长潜力，确保改善患者的治疗效果和市场扩张。

主要市场统计
基准年[2023] 14.1亿美元
预测年份 [2024] 15.1亿美元
预测年份 [2030] 22.5亿美元
复合年增长率（%） 6.85%

市场动态：快速发展的脑血管摄影市场的关键市场洞察

供需的动态交互作用正在改变脑血管摄影市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 脑血管疾病和损伤的发生率增加
    • 偏好微创手术或影像导引手术
    • 提高对脑​​部疾病的认识和早期诊断的倡议
  • 市场限制因素
    • 血管造影术手术的复杂医疗费用
  • 市场机会
    • 脑血管摄影技术进展
    • 对混合血管造影术成像系统的需求不断增长
  • 市场挑战
    • 接受脑血管摄影可能产生的副作用

波特五力：驾驭脑血管摄影市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对脑血管摄影市场的影响

外部宏观环境因素对脑血管摄影市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解脑血管摄影市场竞争状况

对脑血管摄影市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵脑血管摄影市场厂商绩效评估

FPNV定位矩阵是评估脑血管摄影市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了脑血管摄影市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，脑血管摄影市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 脑血管疾病和创伤的发生率增加
      • 优先考虑微创手术和影像导引手术
      • 努力提高对脑部疾病的认识和早期诊断
    • 抑制因素
      • 血管造影术复杂报销
    • 机会
      • 脑血管摄影技术进展
      • 对混合血管造影术成像系统的需求不断增长
    • 任务
      • 接受脑血管摄影的潜在副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章脑血管摄影市场：副产品

  • 电脑断层血管造影术
  • 磁振血管造影术
  • X血管造影术

第七章脑血管摄影市场：依给药途径

  • 经股骨
  • 经桡动脉

第八章脑血管摄影市场：依应用分类

  • 诊断
  • 治疗药物

第九章脑血管摄影市场：依最终用户分类

  • 门诊手术中心
  • 医院/诊所

第十章北美与南美脑血管摄影市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区脑血管摄影市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的脑血管摄影市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Cook Group Incorporated
  • GE Healthcare Technologies Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • InterMed Medical Limited
  • Koninklijke Philips NV
  • MEDTRON AG
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Samsung Medison Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers company
  • St. Stone Medical Devices Private Limited
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-8E22B619330B

The Cerebral Angiography Market was valued at USD 1.41 billion in 2023, expected to reach USD 1.51 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 2.25 billion by 2030.

Cerebral angiography, a diagnostic imaging technique used to visualize blood vessels in the brain, plays a pivotal role in the diagnosis and management of various neurological conditions, including aneurysms, strokes, and vascular malformations. The necessity for cerebral angiography stems from its ability to provide detailed images of cerebral vasculature, enabling precise assessment and intervention planning. Its applications extend across hospitals, specialized clinics, and research institutions, serving both diagnostic and therapeutic purposes. The end-use scope is broad, encompassing neurology departments, interventional radiology units, and increasing utilization in research on neurovascular diseases. Market growth is primarily driven by rising incidences of cerebrovascular diseases, technological advancements in imaging systems, and the increasing demand for minimally invasive procedures. Potential opportunities lie in developing portable and cost-effective imaging solutions, enhancing digital imaging technologies, and improving contrast agents for better image clarity and safety. Investments in artificial intelligence for image analysis and integration of machine learning for predictive diagnostics represent a significant growth avenue. However, market expansion is challenged by high procedure costs, stringent regulatory approvals, and the need for skilled healthcare professionals. Additionally, limited access in low-income regions poses a barrier to widespread adoption. To address these challenges, innovation can focus on reducing costs, expanding telemedicine capabilities, and developing training programs for medical staff. The nature of the market is competitive and dynamic, driven by continuous technological evolution and partnerships among healthcare providers and tech companies. Companies can capitalize on emerging trends by investing in R&D for AI-driven diagnostic tools and enhancing cross-disciplinary collaborations. By addressing current limitations and focusing on these areas of innovation, stakeholders can harness the growth potential within the cerebral angiography market, ensuring improved patient outcomes and expanded market reach.

KEY MARKET STATISTICS
Base Year [2023] USD 1.41 billion
Estimated Year [2024] USD 1.51 billion
Forecast Year [2030] USD 2.25 billion
CAGR (%) 6.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cerebral Angiography Market

The Cerebral Angiography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of cerebrovascular diseases and injuries
    • Preference for minimally invasive and image-guided surgeries
    • Initiatives to raise awareness and early diagnosis of brain disorders
  • Market Restraints
    • Complex reimbursement for angiography procedures
  • Market Opportunities
    • Technological advancements in cerebral angiography
    • Expanding demand for hybrid angiography imaging systems
  • Market Challenges
    • Potential side effects of undergoing cerebral angiography

Porter's Five Forces: A Strategic Tool for Navigating the Cerebral Angiography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cerebral Angiography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cerebral Angiography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cerebral Angiography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cerebral Angiography Market

A detailed market share analysis in the Cerebral Angiography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cerebral Angiography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cerebral Angiography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cerebral Angiography Market

A strategic analysis of the Cerebral Angiography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cerebral Angiography Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health, Inc., Carestream Health, Inc., Cook Group Incorporated, GE Healthcare Technologies Inc., Hitachi Medical Corporation, Hologic, Inc., InterMed Medical Limited, Koninklijke Philips N.V., MEDTRON AG, Medtronic PLC, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Samsung Medison Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, St. Stone Medical Devices Private Limited, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Cerebral Angiography Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Computed Tomography Angiography, Magnetic Resonance Angiography, and X-ray Angiography.
  • Based on Route of Administration, market is studied across Transfemoral and Transradial.
  • Based on Application, market is studied across Diagnostics and Therapeutics.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of cerebrovascular diseases and injuries
      • 5.1.1.2. Preference for minimally invasive and image-guided surgeries
      • 5.1.1.3. Initiatives to raise awareness and early diagnosis of brain disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Complex reimbursement for angiography procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in cerebral angiography
      • 5.1.3.2. Expanding demand for hybrid angiography imaging systems
    • 5.1.4. Challenges
      • 5.1.4.1. Potential side effects of undergoing cerebral angiography
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cerebral Angiography Market, by Product

  • 6.1. Introduction
  • 6.2. Computed Tomography Angiography
  • 6.3. Magnetic Resonance Angiography
  • 6.4. X-ray Angiography

7. Cerebral Angiography Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Transfemoral
  • 7.3. Transradial

8. Cerebral Angiography Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Therapeutics

9. Cerebral Angiography Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals & Clinics

10. Americas Cerebral Angiography Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cerebral Angiography Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cerebral Angiography Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AngioDynamics, Inc.
  • 3. B. Braun Melsungen AG
  • 4. Becton, Dickinson and Company
  • 5. Boston Scientific Corporation
  • 6. Canon Medical Systems Corporation
  • 7. Cardinal Health, Inc.
  • 8. Carestream Health, Inc.
  • 9. Cook Group Incorporated
  • 10. GE Healthcare Technologies Inc.
  • 11. Hitachi Medical Corporation
  • 12. Hologic, Inc.
  • 13. InterMed Medical Limited
  • 14. Koninklijke Philips N.V.
  • 15. MEDTRON AG
  • 16. Medtronic PLC
  • 17. Merit Medical Systems, Inc.
  • 18. MicroPort Scientific Corporation
  • 19. Penumbra, Inc.
  • 20. Samsung Medison Co., Ltd.
  • 21. Shimadzu Corporation
  • 22. Siemens Healthineers company
  • 23. St. Stone Medical Devices Private Limited
  • 24. Stryker Corporation
  • 25. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. CEREBRAL ANGIOGRAPHY MARKET RESEARCH PROCESS
  • FIGURE 2. CEREBRAL ANGIOGRAPHY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CEREBRAL ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CEREBRAL ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CEREBRAL ANGIOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CEREBRAL ANGIOGRAPHY MARKET DYNAMICS
  • TABLE 7. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COMPUTED TOMOGRAPHY ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY MAGNETIC RESONANCE ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY X-RAY ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY TRANSRADIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CEREBRAL ANGIOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. CEREBRAL ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. CEREBRAL ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023